3) the intervention agent was semaglutide, and placebo was comparison one
Primary mechanism
We reviewed the latest evidence available, which includes: 1 systematic review, 1 narrative review, 1 general review and 1 pilot study in humans
Common side effects of compounded semaglutide can include nausea, vomiting, diarrhea, constipation, and fatigue
Cycle Rationale Cycle rationale involves: Preventing receptor desensitization Allowing body to reset natural peptide production Maintaining copper balance to avoid accumulation Optimizing long-term efficacy Vial Requirements Per Cycle For 50 mg vials at 1-2 mg daily dosing: 2-3 vials (84-168 mg total) 3-4 vials (126-252 mg total) 4-5 vials (168-336 mg total) Storage Requirements Lyophilized powder storage optimally occurs at -20C (freezer) until reconstitution, with alternatives of 2-8C (refrigerator) or cool, dry place
This result indicates that the reduced melanin production is not attributable to the cytotoxicity of T1 and T1 can be a safe skin-lightening agent without influencing melanocyte growth
